Tumor suppressive role of the epigenetic master regulator BRD3 in colorectal cancer
Cancer Science · 2024
DOI: 10.1111/cas.16129 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2024. Verfasst von Masahiro Hashimoto und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Kyushu University Beppu Hospital, Beppu, Japan. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Transcription Factors, Gene Expression Regulation, Neoplastic, Epigenesis, Genetic. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Agency for Medical Research and Development, Takeda Science Foundation, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Bromodomain and extraterminal domain (BET) family proteins are epigenetic master regulators of gene expression via recognition of acetylated histones and recruitment of transcription factors and co‐activators to chromatin. Hence, BET family proteins have emerged as promising therapeutic targets in cancer. In this study, we examined the functional role of bromodomain containing 3 (BRD3), a BET family protein, in colorectal cancer (CRC). In vitro and vivo analyses using BRD3 ‐knockdown or BRD3‐overexpressing CRC cells showed that BRD3 suppressed tumor growth and cell cycle G1/S transition and induced p21 expression. Clinical analysis of CRC datasets from our hospital or The Cancer Genome Atlas revealed that BET family genes, including BRD3 , were overexpressed in tumor tissues. In immunohistochemical analyses, BRD3 was observed mainly in the nucleus of CRC cells. According to single‐cell RNA sequencing in untreated CRC tissues, BRD3 was highly expressed in malignant epithelial cells, and cell cycle checkpoint‐related pathways were enriched in the epithelial cells with high BRD3 expression. Spatial transcriptomic and single‐cell RNA sequencing analyses of CRC tissues showed that BRD3 expression was positively associated with high p21 expression. Furthermore, overexpression of BRD3 combined with knockdown of, a driver gene in the BRD family, showed strong inhibition of CRC cells in vitro. In conclusion, we demonstrated a novel tumor suppressive role of BRD3 that inhibits tumor growth by cell cycle inhibition in part via induction of p21 expression. BRD3 activation might be a novel therapeutic approach for CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Kyushu University Beppu Hospital, Beppu, Japan.
- Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Japan.
- Department of Pathology, Kyushu University Beppu Hospital, Beppu, Japan.
- Tokai University School of Medicine, Isehara, Japan.
ORCID-Profile: Masahiro Hashimoto, Takaaki Masuda, Kensuke Koike, Takeo Toshima, Hidetoshi Eguchi, Koshi Mimori
Förderung
- Japan Agency for Medical Research and Development
- Takeda Science Foundation
- Japan Society for the Promotion of Science
- Princess Takamatsu Cancer Research Fund
- OITA Cancer Research Foundation
Zitieren
APA
Hashimoto, M., Masuda, T., Nakano, Y., Tobo, T., Saito, H., Koike, K., Takahashi, J., Abe, T., Ando, Y., Ozato, Y., Hosoda, K., Higuchi, S., Hisamatsu, Y., Toshima, T., Yonemura, Y., Hata, T., Uemura, M., Eguchi, H., Doki, Y., …, & Mimori, K. (2024). Tumor suppressive role of the epigenetic master regulator BRD3 in colorectal cancer. Cancer Science. https://doi.org/10.1111/cas.16129
Vancouver
Hashimoto M, Masuda T, Nakano Y, Tobo T, Saito H, Koike K, et al. Tumor suppressive role of the epigenetic master regulator BRD3 in colorectal cancer. Cancer Science. 2024. doi:10.1111/cas.16129
BibTeX
@article{Hashimoto2024,
author = {Hashimoto, Masahiro and Masuda, Takaaki and Nakano, Yusuke and Tobo, Taro and Saito, Hideyuki and Koike, Kensuke and Takahashi, Junichi and Abe, Tadashi and Ando, Yuki and Ozato, Yuki and Hosoda, Kiyotaka and Higuchi, Satoshi and Hisamatsu, Yuichi and Toshima, Takeo and Yonemura, Yusuke and Hata, Tsuyoshi and Uemura, Mamoru and Eguchi, Hidetoshi and Doki, Yuichiro and Mori, Masaki and Mimori, Koshi},
title = {Tumor suppressive role of the epigenetic master regulator BRD3 in colorectal cancer},
journal = {Cancer Science},
year = {2024},
doi = {10.1111/cas.16129}
}
EUVIMED